- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
Tickers
NVAX
From InvestorPlace
US Stock Futures Slide On Inflation Fears: Analyst Sees Risk-Off Mood As Debt-Ceiling Crisis Looms
May 09, 2023
From Benzinga
From Benzinga
From Benzinga
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
May 01, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 27, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 24, 2023
From Benzinga
2 Popular Stocks to Avoid in April and Beyond
April 24, 2023
From Motley Fool
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge
April 24, 2023
From Motley Fool
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 20, 2023
From Benzinga
7 Short-Squeeze Stocks That Are Breaking All the Rules
April 20, 2023
From InvestorPlace
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
April 18, 2023
From Benzinga
From Motley Fool
3 Former High-Flying Stocks Down 92% to 99% That Billionaire Investors Can't Stop Buying
April 18, 2023
From Motley Fool
AMC Entertainment Is Most Expensive Stock For Short Sellers, But What Other Stocks Top The List?
April 17, 2023
From Benzinga
7 Short-Squeeze Stocks That Are Driving Hedge Funds Crazy
April 16, 2023
From InvestorPlace
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
From InvestorPlace
Stop! Don’t Infect Your Portfolio With Toxic Novavax Stock.
April 15, 2023
Tickers
NVAX
From InvestorPlace
From Benzinga
Novavax Plans to Cut $50 Million in Costs, COVID-19 Vaccine Remains Only Marketed Product
April 13, 2023
Tickers
NVAX
From Benzinga
From InvestorPlace
From InvestorPlace
Why Is Novavax (NVAX) Stock Moving Today?
April 12, 2023
From InvestorPlace
Short Interest Sector Focus: Healthcare Sector
April 04, 2023
From Benzinga
1 Stock to Buy and 1 to Avoid Before the Next Bull Market
April 04, 2023
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 03, 2023
From Benzinga
7 ‘Fallen Angel’ Stocks to Sell Before They Plummet Again
April 02, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.